在全新作用机制抗肿瘤创新药物开发领域内拥有多项核心技术，特别是在蛋白-蛋白相互作用靶点领域内的药物设计技术处于领先地位，拥有相关国内外发明专利100多件。公司基于自有核心技术体系基础之上，短短几年之内，就成功完成了在肿瘤、乙肝及与衰老相关疾病领域内的产品布局，构建了优质的梯度科学合理的产品管线，其中有7项原创新药先后进入到中国、美国及澳大利亚Ⅰ-Ⅱ期临床开发阶段，并有多项原创新药处于临床前研究或更早期的研究阶段。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
